Tumor and bone marrow uptakes on [18F]fluorodeoxyglucose positron emission tomography/computed tomography predict prognosis in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy. [electronic resource]
Producer: 20171127Description: e8655 p. digitalISSN:- 1536-5964
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Immunological -- therapeutic use
- Female
- Fluorodeoxyglucose F18
- Follow-Up Studies
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Large B-Cell, Diffuse -- diagnostic imaging
- Male
- Middle Aged
- Multivariate Analysis
- Positron Emission Tomography Computed Tomography
- Prognosis
- Proportional Hazards Models
- Radiopharmaceuticals
- Retrospective Studies
- Rituximab -- therapeutic use
- Whole Body Imaging
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.